{"product_id":"mk677ibutamoren-100x10mgg","title":"MK677(Ibutamoren) 100x10mg","description":"\u003cp style=\"text-align: center;\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eNOT FOR HUMAN CONSUMPTION\u003cmeta charset=\"UTF-8\"\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"607\" data-start=\"53\"\u003e\u003cstrong\u003eMK677 \u003c\/strong\u003e(ibutamoren) is an oral, non-peptide \u003cstrong data-end=\"168\" data-start=\"130\"\u003eghrelin-receptor (GHSR-1a) agonist\u003c\/strong\u003e that provokes \u003cstrong data-end=\"224\" data-start=\"183\"\u003epulsatile growth-hormone (GH) release\u003c\/strong\u003e and raises circulating \u003cstrong data-end=\"257\" data-start=\"248\"\u003eIGF-1\u003c\/strong\u003e. Unlike injectable secretagogues (GHRP-2\/hexarelin), MK-677 is \u003cstrong data-end=\"340\" data-start=\"321\"\u003eonce-daily oral\u003c\/strong\u003e, engages central orexigenic circuits (NPY\/AgRP), and modestly elevates \u003cstrong data-end=\"424\" data-start=\"412\"\u003ecortisol\u003c\/strong\u003e and \u003cstrong data-end=\"442\" data-start=\"429\"\u003eprolactin\u003c\/strong\u003e. It does \u003cstrong data-end=\"459\" data-start=\"452\"\u003enot\u003c\/strong\u003e activate the androgen receptor and is \u003cstrong data-end=\"512\" data-start=\"498\"\u003enot a SARM\u003c\/strong\u003e. MK-677 is \u003cstrong data-end=\"548\" data-start=\"524\"\u003enot FDA\/EMA-approved\u003c\/strong\u003e and is \u003cstrong data-end=\"578\" data-start=\"556\"\u003eprohibited by WADA\u003c\/strong\u003e as a GH-releasing substance.\u003c\/p\u003e\n\u003chr data-end=\"612\" data-start=\"609\"\u003e\n\u003ch3 data-end=\"671\" data-start=\"614\"\u003eAdditional Benefits of MK-677 Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"2885\" data-start=\"673\"\u003e\n\u003cthead data-end=\"701\" data-start=\"673\"\u003e\n\u003ctr data-end=\"701\" data-start=\"673\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"683\" data-start=\"673\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"701\" data-start=\"683\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2885\" data-start=\"712\"\u003e\n\u003ctr data-end=\"1010\" data-start=\"712\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"754\" data-start=\"712\"\u003e\u003cstrong data-end=\"753\" data-start=\"714\"\u003e1 Lean-mass accrual in older adults\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1010\" data-start=\"754\" data-col-size=\"xl\"\u003eDaily MK-677 \u003cstrong data-end=\"796\" data-start=\"769\"\u003eincreases fat-free mass\u003c\/strong\u003e over months with parallel \u003cstrong data-end=\"838\" data-start=\"823\"\u003eIGF-1 rises\u003c\/strong\u003e, approximating youthful GH\/IGF-1 levels; strength\/function show supportive trends when combined with resistance training. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Annals of Internal Medicine; JCEM\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1280\" data-start=\"1011\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1047\" data-start=\"1011\"\u003e\u003cstrong data-end=\"1046\" data-start=\"1013\"\u003e2 Bone-turnover \u0026amp; BMD signals\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1280\" data-start=\"1047\" data-col-size=\"xl\"\u003eIncreases \u003cstrong data-end=\"1085\" data-start=\"1059\"\u003ebone-formation markers\u003c\/strong\u003e (e.g., P1NP, osteocalcin) and \u003cstrong data-end=\"1146\" data-start=\"1116\"\u003ereduces resorption markers\u003c\/strong\u003e; longer-term cohorts report \u003cstrong data-end=\"1195\" data-start=\"1175\"\u003eBMD improvements\u003c\/strong\u003e, supporting anti-frailty potential. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Bone; Osteoporosis International\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1487\" data-start=\"1281\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1308\" data-start=\"1281\"\u003e\u003cstrong data-end=\"1307\" data-start=\"1283\"\u003e3 Sleep architecture\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1487\" data-start=\"1308\" data-col-size=\"xl\"\u003e\n\u003cstrong data-end=\"1335\" data-start=\"1310\"\u003eSlow-wave sleep (SWS)\u003c\/strong\u003e and REM density improve with bedtime dosing, aligning with physiologic GH pulses and next-day vitality. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sleep; Psychoneuroendocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1734\" data-start=\"1488\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1534\" data-start=\"1488\"\u003e\u003cstrong data-end=\"1533\" data-start=\"1490\"\u003e4 Appetite \u0026amp; weight in catabolic states\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1734\" data-start=\"1534\" data-col-size=\"xl\"\u003eRobust \u003cstrong data-end=\"1564\" data-start=\"1543\"\u003eorexigenic effect\u003c\/strong\u003e increases caloric intake; cachexia\/rehab pilots show \u003cstrong data-end=\"1642\" data-start=\"1618\"\u003eweight and FFM gains\u003c\/strong\u003ewith acceptable tolerability. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Nutrition; Supportive Care in Cancer\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1989\" data-start=\"1735\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1768\" data-start=\"1735\"\u003e\u003cstrong data-end=\"1767\" data-start=\"1737\"\u003e5 Glucose handling (mixed)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1989\" data-start=\"1768\" data-col-size=\"xl\"\u003eSome studies show \u003cstrong data-end=\"1817\" data-start=\"1788\"\u003einsulin-sensitivity drift\u003c\/strong\u003e (↑ fasting glucose\/insulin); others report \u003cstrong data-end=\"1881\" data-start=\"1861\"\u003eneutral outcomes\u003c\/strong\u003e with lifestyle control—underscores need for glycaemic monitoring. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Diabetes Care; Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2253\" data-start=\"1990\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2039\" data-start=\"1990\"\u003e\u003cstrong data-end=\"2038\" data-start=\"1992\"\u003e6 Functional recovery after illness\/injury\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2253\" data-start=\"2039\" data-col-size=\"xl\"\u003eEarly programs evaluate MK-677 to \u003cstrong data-end=\"2099\" data-start=\"2075\"\u003espeed rehabilitation\u003c\/strong\u003e, leveraging appetite + anabolic endocrine support. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Geriatrics \u0026amp; Gerontology International; Archives of Physical Medicine \u0026amp; Rehabilitation\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2456\" data-start=\"2254\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2305\" data-start=\"2254\"\u003e\u003cstrong data-end=\"2304\" data-start=\"2256\"\u003e7 GH-axis restoration in age-related decline\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2456\" data-start=\"2305\" data-col-size=\"xl\"\u003eElevates \u003cstrong data-end=\"2333\" data-start=\"2316\"\u003eIGF-1\/IGFBP-3\u003c\/strong\u003e toward youthful ranges without exogenous GH injections; preserves \u003cstrong data-end=\"2415\" data-start=\"2400\"\u003epulsatility\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrine Reviews; JCEM\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2683\" data-start=\"2457\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2489\" data-start=\"2457\"\u003e\u003cstrong data-end=\"2488\" data-start=\"2459\"\u003e8 Quality-of-life domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2683\" data-start=\"2489\" data-col-size=\"xl\"\u003eParticipants frequently report \u003cstrong data-end=\"2570\" data-start=\"2522\"\u003ebetter sleep quality, appetite, and recovery\u003c\/strong\u003e; validated PROs are being incorporated into trials. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrine Practice; Quality of Life Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2885\" data-start=\"2684\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2716\" data-start=\"2684\"\u003e\u003cstrong data-end=\"2715\" data-start=\"2686\"\u003e9 Convenience \u0026amp; adherence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2885\" data-start=\"2716\" data-col-size=\"xl\"\u003e\n\u003cstrong data-end=\"2737\" data-start=\"2718\"\u003eOnce-daily oral\u003c\/strong\u003e regimen improves persistence versus injectable GH or peptide secretagogues. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Therapeutics; Patient Preference and Adherence\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"2890\" data-start=\"2887\"\u003e\n\u003ch2 data-end=\"2927\" data-start=\"2892\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"2964\" data-start=\"2929\"\u003e2.1 Receptor Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-end=\"3291\" data-start=\"2965\"\u003eMK-677 binds \u003cstrong data-end=\"2989\" data-start=\"2978\"\u003eGHSR-1a\u003c\/strong\u003e (GPCR) on hypothalamic neurons and pituitary somatotrophs → \u003cstrong data-end=\"3073\" data-start=\"3050\"\u003eGαq\/11–PLC–IP₃\/Ca²⁺\u003c\/strong\u003esignaling → GH vesicle exocytosis. It \u003cstrong data-end=\"3126\" data-start=\"3112\"\u003esynergizes\u003c\/strong\u003e with endogenous GHRH and is \u003cstrong data-end=\"3175\" data-start=\"3155\"\u003epartly countered\u003c\/strong\u003e by somatostatin. Central GHSR activation also drives \u003cstrong data-end=\"3241\" data-start=\"3229\"\u003eNPY\/AgRP\u003c\/strong\u003e orexigenic pathways and modulates sleep circuits.\u003c\/p\u003e\n\u003ch3 data-end=\"3320\" data-start=\"3293\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3709\" data-start=\"3322\"\u003e\n\u003cthead data-end=\"3364\" data-start=\"3322\"\u003e\n\u003ctr data-end=\"3364\" data-start=\"3322\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3332\" data-start=\"3322\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3353\" data-start=\"3332\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3364\" data-start=\"3353\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3709\" data-start=\"3379\"\u003e\n\u003ctr data-end=\"3485\" data-start=\"3379\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3405\" data-start=\"3379\"\u003eGH → \u003cstrong data-end=\"3404\" data-start=\"3386\"\u003eGHR–JAK2–STAT5\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3459\" data-start=\"3405\"\u003e↑ \u003cstrong data-end=\"3426\" data-start=\"3409\"\u003eIGF-1\/IGFBP-3\u003c\/strong\u003e, ↑ protein synthesis, lipolysis\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3485\" data-start=\"3459\"\u003eLiver, muscle, adipose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3560\" data-start=\"3486\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3508\" data-start=\"3486\"\u003eGHSR → \u003cstrong data-end=\"3507\" data-start=\"3495\"\u003eNPY\/AgRP\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3541\" data-start=\"3508\"\u003e↑ appetite, ↑ gastric motility\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3560\" data-start=\"3541\"\u003eHypothalamus\/GI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3635\" data-start=\"3561\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3581\" data-start=\"3561\"\u003eSleep–GH coupling\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3628\" data-start=\"3581\"\u003e↑ SWS\/REM consolidation, nocturnal GH pulses\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3635\" data-start=\"3628\"\u003eCNS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3709\" data-start=\"3636\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3660\" data-start=\"3636\"\u003eBone turnover signals\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3697\" data-start=\"3660\"\u003e↑ formation markers; BMD over time\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3709\" data-start=\"3697\"\u003eSkeleton\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3714\" data-start=\"3711\"\u003e\n\u003ch2 data-end=\"3738\" data-start=\"3716\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4114\" data-start=\"3740\"\u003e\n\u003cli data-end=\"3773\" data-start=\"3740\"\u003e\n\u003cp data-end=\"3773\" data-start=\"3742\"\u003e\u003cstrong data-end=\"3752\" data-start=\"3742\"\u003eRoute:\u003c\/strong\u003e Oral (once daily).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3817\" data-start=\"3774\"\u003e\n\u003cp data-end=\"3817\" data-start=\"3776\"\u003e\u003cstrong data-end=\"3791\" data-start=\"3776\"\u003eAbsorption:\u003c\/strong\u003e Rapid; \u003cstrong data-end=\"3814\" data-start=\"3799\"\u003eTmax ~1–2 h\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3925\" data-start=\"3818\"\u003e\n\u003cp data-end=\"3925\" data-start=\"3820\"\u003e\u003cstrong data-end=\"3834\" data-start=\"3820\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-end=\"3845\" data-start=\"3835\"\u003e~4–6 h\u003c\/strong\u003e; \u003cstrong data-end=\"3880\" data-start=\"3847\"\u003eIGF-1 elevation persists 24 h\u003c\/strong\u003e with daily dosing due to GH-axis dynamics.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4044\" data-start=\"3926\"\u003e\n\u003cp data-end=\"4044\" data-start=\"3928\"\u003e\u003cstrong data-end=\"3943\" data-start=\"3928\"\u003eMetabolism:\u003c\/strong\u003e Hepatic; \u003cstrong data-end=\"3993\" data-start=\"3953\"\u003eCYP3A4 involvement reported in vitro\u003c\/strong\u003e (DDI potential with strong inhibitors\/inducers).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4114\" data-start=\"4045\"\u003e\n\u003cp data-end=\"4114\" data-start=\"4047\"\u003e\u003cstrong data-end=\"4063\" data-start=\"4047\"\u003eElimination:\u003c\/strong\u003e Hepatic\/renal metabolites; high protein binding.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4119\" data-start=\"4116\"\u003e\n\u003ch2 data-end=\"4166\" data-start=\"4121\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"4194\" data-start=\"4168\"\u003e4.1 Aging\/Sarcopenia\u003c\/h3\u003e\n\u003cp data-end=\"4407\" data-start=\"4195\"\u003eRandomized trials in older adults show \u003cstrong data-end=\"4263\" data-start=\"4234\"\u003esustained IGF-1 increases\u003c\/strong\u003e, \u003cstrong data-end=\"4278\" data-start=\"4265\"\u003eFFM gains\u003c\/strong\u003e, improved \u003cstrong data-end=\"4311\" data-start=\"4289\"\u003esleep architecture\u003c\/strong\u003e, and favorable trends in \u003cstrong data-end=\"4367\" data-start=\"4337\"\u003estrength and gait measures\u003c\/strong\u003e, particularly with structured exercise.\u003c\/p\u003e\n\u003ch3 data-end=\"4430\" data-start=\"4409\"\u003e4.2 Bone Health\u003c\/h3\u003e\n\u003cp data-end=\"4589\" data-start=\"4431\"\u003eMarkers of \u003cstrong data-end=\"4460\" data-start=\"4442\"\u003ebone formation\u003c\/strong\u003e rise within weeks; \u003cstrong data-end=\"4487\" data-start=\"4480\"\u003eBMD\u003c\/strong\u003e benefits emerge over longer courses—supporting evaluation for \u003cstrong data-end=\"4577\" data-start=\"4550\"\u003eosteopenia\/osteoporosis\u003c\/strong\u003e in frailty.\u003c\/p\u003e\n\u003ch3 data-end=\"4627\" data-start=\"4591\"\u003e4.3 Metabolism \u0026amp; Diabetes Risk\u003c\/h3\u003e\n\u003cp data-end=\"4828\" data-start=\"4628\"\u003eIn mixed-risk cohorts, MK-677 may \u003cstrong data-end=\"4695\" data-start=\"4662\"\u003eraise fasting glucose\/insulin\u003c\/strong\u003e and \u003cstrong data-end=\"4730\" data-start=\"4700\"\u003ereduce insulin sensitivity\u003c\/strong\u003e; effects are \u003cstrong data-end=\"4789\" data-start=\"4744\"\u003edose-, duration-, and phenotype-dependent\u003c\/strong\u003e, emphasizing \u003cstrong data-end=\"4827\" data-start=\"4803\"\u003eglycaemic monitoring\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cblockquote data-end=\"5016\" data-start=\"4830\"\u003e\n\u003cp data-end=\"5016\" data-start=\"4832\"\u003e\u003cstrong data-end=\"4858\" data-start=\"4832\"\u003eEvidence quality note:\u003c\/strong\u003e Human data include \u003cstrong data-end=\"4910\" data-start=\"4878\"\u003emultiple small–moderate RCTs\u003c\/strong\u003e and mechanistic studies; \u003cstrong data-end=\"4958\" data-start=\"4936\"\u003elong-term outcomes\u003c\/strong\u003e (fractures, disability, CV events) remain \u003cstrong data-end=\"5015\" data-start=\"5001\"\u003eunresolved\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-end=\"5021\" data-start=\"5018\"\u003e\n\u003ch2 data-end=\"5056\" data-start=\"5023\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"5588\" data-start=\"5058\"\u003e\n\u003cthead data-end=\"5096\" data-start=\"5058\"\u003e\n\u003ctr data-end=\"5096\" data-start=\"5058\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5066\" data-start=\"5058\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5078\" data-start=\"5066\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5096\" data-start=\"5078\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5588\" data-start=\"5111\"\u003e\n\u003ctr data-end=\"5226\" data-start=\"5111\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5136\" data-start=\"5111\"\u003e\u003cstrong data-end=\"5135\" data-start=\"5113\"\u003eSarcopenia\/frailty\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5181\" data-start=\"5136\"\u003eOral anabolic + sleep and appetite support\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5226\" data-start=\"5181\"\u003ePhase 2–style signals; larger RCTs needed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5309\" data-start=\"5227\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5257\" data-start=\"5227\"\u003e\u003cstrong data-end=\"5256\" data-start=\"5229\"\u003eOsteopenia\/osteoporosis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5294\" data-start=\"5257\"\u003eBone-turnover and BMD improvements\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5309\" data-start=\"5294\"\u003eExploratory\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5398\" data-start=\"5310\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5343\" data-start=\"5310\"\u003e\u003cstrong data-end=\"5342\" data-start=\"5312\"\u003eCachexia (cancer\/COPD\/CHF)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5377\" data-start=\"5343\"\u003eOrexigenic + GH\/IGF-1 anabolism\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5398\" data-start=\"5377\"\u003ePilot\/feasibility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5488\" data-start=\"5399\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5422\" data-start=\"5399\"\u003e\u003cstrong data-end=\"5421\" data-start=\"5401\"\u003ePost-acute rehab\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5465\" data-start=\"5422\"\u003eAppetite\/FFM restoration to aid recovery\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5488\" data-start=\"5465\"\u003eEarly translational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5588\" data-start=\"5489\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5525\" data-start=\"5489\"\u003e\u003cstrong data-end=\"5524\" data-start=\"5491\"\u003eSleep disorders (SWS decline)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5568\" data-start=\"5525\"\u003eSWS augmentation with endocrine coupling\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5588\" data-start=\"5568\"\u003eProof-of-concept\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5593\" data-start=\"5590\"\u003e\n\u003ch2 data-end=\"5624\" data-start=\"5595\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"6436\" data-start=\"5626\"\u003e\n\u003cli data-end=\"5781\" data-start=\"5626\"\u003e\n\u003cp data-end=\"5781\" data-start=\"5628\"\u003e\u003cstrong data-end=\"5639\" data-start=\"5628\"\u003eCommon:\u003c\/strong\u003e \u003cstrong data-end=\"5669\" data-start=\"5640\"\u003eIncreased appetite\/weight\u003c\/strong\u003e, \u003cstrong data-end=\"5691\" data-start=\"5671\"\u003eperipheral edema\u003c\/strong\u003e, \u003cstrong data-end=\"5747\" data-start=\"5693\"\u003etransient paresthesias\/carpal-tunnel-like symptoms\u003c\/strong\u003e, \u003cstrong data-end=\"5760\" data-start=\"5749\"\u003efatigue\u003c\/strong\u003e, \u003cstrong data-end=\"5778\" data-start=\"5762\"\u003evivid dreams\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5893\" data-start=\"5782\"\u003e\n\u003cp data-end=\"5893\" data-start=\"5784\"\u003e\u003cstrong data-end=\"5798\" data-start=\"5784\"\u003eEndocrine:\u003c\/strong\u003e \u003cstrong data-end=\"5818\" data-start=\"5799\"\u003eIGF-1 elevation\u003c\/strong\u003e (target age-normal range); \u003cstrong data-end=\"5872\" data-start=\"5846\"\u003eprolactin and cortisol\u003c\/strong\u003e may rise modestly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6006\" data-start=\"5894\"\u003e\n\u003cp data-end=\"6006\" data-start=\"5896\"\u003e\u003cstrong data-end=\"5910\" data-start=\"5896\"\u003eMetabolic:\u003c\/strong\u003e \u003cstrong data-end=\"5941\" data-start=\"5911\"\u003eFPG\/HbA1c can drift upward\u003c\/strong\u003e; monitor in prediabetes\/diabetes and adjust therapy as needed.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6093\" data-start=\"6007\"\u003e\n\u003cp data-end=\"6093\" data-start=\"6009\"\u003e\u003cstrong data-end=\"6022\" data-start=\"6009\"\u003eCV\/Renal:\u003c\/strong\u003e Edema and \u003cstrong data-end=\"6054\" data-start=\"6033\"\u003emild BP increases\u003c\/strong\u003e can occur—use caution in \u003cstrong data-end=\"6090\" data-start=\"6080\"\u003eHF\/CKD\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6136\" data-start=\"6094\"\u003e\n\u003cp data-end=\"6136\" data-start=\"6096\"\u003e\u003cstrong data-end=\"6103\" data-start=\"6096\"\u003eGI:\u003c\/strong\u003e \u003cstrong data-end=\"6119\" data-start=\"6104\"\u003eNausea\/GERD\u003c\/strong\u003e in a minority.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6184\" data-start=\"6137\"\u003e\n\u003cp data-end=\"6184\" data-start=\"6139\"\u003e\u003cstrong data-end=\"6154\" data-start=\"6139\"\u003eNeuropsych:\u003c\/strong\u003e Rare insomnia\/irritability.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6299\" data-start=\"6185\"\u003e\n\u003cp data-end=\"6299\" data-start=\"6187\"\u003e\u003cstrong data-end=\"6209\" data-start=\"6187\"\u003eDrug interactions:\u003c\/strong\u003e Caution with \u003cstrong data-end=\"6260\" data-start=\"6223\"\u003estrong CYP3A4 inhibitors\/inducers\u003c\/strong\u003e (theoretical\/limited clinical data).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6436\" data-start=\"6300\"\u003e\n\u003cp data-end=\"6436\" data-start=\"6302\"\u003e\u003cstrong data-end=\"6332\" data-start=\"6302\"\u003eContraindications\/Caution:\u003c\/strong\u003e Active malignancy under evaluation (IGF-1 biology), pregnancy, uncontrolled diabetes, decompensated HF.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"6467\" data-start=\"6438\"\u003e\u003cstrong data-end=\"6467\" data-start=\"6438\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"7162\" data-start=\"6469\"\u003e\n\u003cthead data-end=\"6607\" data-start=\"6469\"\u003e\n\u003ctr data-end=\"6607\" data-start=\"6469\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6479\" data-start=\"6469\"\u003eConcern\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6512\" data-start=\"6479\"\u003e\u003cstrong data-end=\"6511\" data-start=\"6481\"\u003eMK-677 (oral GHSR agonist)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6548\" data-start=\"6512\"\u003e\u003cstrong data-end=\"6547\" data-start=\"6514\"\u003eGHRP-2\/Hexarelin (injectable)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6584\" data-start=\"6548\"\u003e\u003cstrong data-end=\"6583\" data-start=\"6550\"\u003eSermorelin\/CJC (GHRH analogs)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6607\" data-start=\"6584\"\u003e\u003cstrong data-end=\"6605\" data-start=\"6586\"\u003eSomatropin (GH)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7162\" data-start=\"6630\"\u003e\n\u003ctr data-end=\"6753\" data-start=\"6630\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6648\" data-start=\"6630\"\u003eRoute\/frequency\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6671\" data-start=\"6648\"\u003e\u003cstrong data-end=\"6670\" data-start=\"6650\"\u003eOral, once daily\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6694\" data-start=\"6671\"\u003eSC\/IN multiple daily\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6731\" data-start=\"6694\"\u003eSC nightly \/ weekly-biweekly (DAC)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6753\" data-start=\"6731\"\u003eSC\/IM daily–weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6863\" data-start=\"6754\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6770\" data-start=\"6754\"\u003eIGF-1 profile\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6794\" data-start=\"6770\"\u003e\u003cstrong data-end=\"6793\" data-start=\"6772\"\u003eSustained, higher\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6816\" data-start=\"6794\"\u003ePulsatile, moderate\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6837\" data-start=\"6816\"\u003ePhysiologic pulses\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6863\" data-start=\"6837\"\u003eDose-driven, sustained\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6933\" data-start=\"6864\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6875\" data-start=\"6864\"\u003eAppetite\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6897\" data-start=\"6875\"\u003e\u003cstrong data-end=\"6896\" data-start=\"6877\"\u003e↑↑ (orexigenic)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6912\" data-start=\"6897\"\u003e↑ (variable)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6922\" data-start=\"6912\"\u003eNeutral\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6933\" data-start=\"6922\"\u003eNeutral\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7004\" data-start=\"6934\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6946\" data-start=\"6934\"\u003eEdema\/CTS\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6961\" data-start=\"6946\"\u003e\u003cstrong data-end=\"6960\" data-start=\"6948\"\u003eModerate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6977\" data-start=\"6961\"\u003eMild–moderate\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6992\" data-start=\"6977\"\u003eLow–moderate\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7004\" data-start=\"6992\"\u003eModerate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7090\" data-start=\"7005\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7023\" data-start=\"7005\"\u003eGlycaemic drift\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7048\" data-start=\"7023\"\u003e\u003cstrong data-end=\"7047\" data-start=\"7025\"\u003eCommon (mild–mod.)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7055\" data-start=\"7048\"\u003eMild\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7072\" data-start=\"7055\"\u003eNeutral–mild ↑\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7090\" data-start=\"7072\"\u003eNeutral–mild ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7162\" data-start=\"7091\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7112\" data-start=\"7091\"\u003eProlactin\/cortisol\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7127\" data-start=\"7112\"\u003e\u003cstrong data-end=\"7126\" data-start=\"7114\"\u003eModest ↑\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7141\" data-start=\"7127\"\u003eTransient ↑\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7151\" data-start=\"7141\"\u003eMinimal\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7162\" data-start=\"7151\"\u003eMinimal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"7167\" data-start=\"7164\"\u003e\n\u003ch2 data-end=\"7195\" data-start=\"7169\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"7450\" data-start=\"7197\"\u003e\n\u003cli data-end=\"7261\" data-start=\"7197\"\u003e\n\u003cp data-end=\"7261\" data-start=\"7199\"\u003e\u003cstrong data-end=\"7213\" data-start=\"7199\"\u003eApprovals:\u003c\/strong\u003e \u003cstrong data-end=\"7222\" data-start=\"7214\"\u003eNone\u003c\/strong\u003e for any indication in major markets.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7339\" data-start=\"7262\"\u003e\n\u003cp data-end=\"7339\" data-start=\"7264\"\u003e\u003cstrong data-end=\"7274\" data-start=\"7264\"\u003eSport:\u003c\/strong\u003e \u003cstrong data-end=\"7294\" data-start=\"7275\"\u003eWADA-prohibited\u003c\/strong\u003e (S2: growth-hormone releasing substances).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7450\" data-start=\"7340\"\u003e\n\u003cp data-end=\"7450\" data-start=\"7342\"\u003e\u003cstrong data-end=\"7353\" data-start=\"7342\"\u003eSupply:\u003c\/strong\u003e Often sold as a \u003cstrong data-end=\"7391\" data-start=\"7370\"\u003eresearch chemical\u003c\/strong\u003e; purity\/adulteration issues are common outside GMP trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7455\" data-start=\"7452\"\u003e\n\u003ch2 data-end=\"7480\" data-start=\"7457\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"8098\" data-start=\"7482\"\u003e\n\u003cli data-end=\"7586\" data-start=\"7482\"\u003e\n\u003cp data-end=\"7586\" data-start=\"7484\"\u003e\u003cstrong data-end=\"7515\" data-start=\"7484\"\u003eLarge, outcome-focused RCTs\u003c\/strong\u003e in \u003cstrong data-end=\"7541\" data-start=\"7519\"\u003esarcopenia\/frailty\u003c\/strong\u003e with function and fall\/fracture endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7651\" data-start=\"7587\"\u003e\n\u003cp data-end=\"7651\" data-start=\"7589\"\u003e\u003cstrong data-end=\"7606\" data-start=\"7589\"\u003eBone programs\u003c\/strong\u003e powered for \u003cstrong data-end=\"7639\" data-start=\"7619\"\u003eBMD and fracture\u003c\/strong\u003e outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7756\" data-start=\"7652\"\u003e\n\u003cp data-end=\"7756\" data-start=\"7654\"\u003e\u003cstrong data-end=\"7683\" data-start=\"7654\"\u003eMetabolic risk management\u003c\/strong\u003e (pre-specified glycaemic thresholds, CGM, cardiometabolic composites).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7847\" data-start=\"7757\"\u003e\n\u003cp data-end=\"7847\" data-start=\"7759\"\u003e\u003cstrong data-end=\"7781\" data-start=\"7759\"\u003eDosing\/time-of-day\u003c\/strong\u003e studies to optimize \u003cstrong data-end=\"7815\" data-start=\"7802\"\u003esleep\/SWS\u003c\/strong\u003e and minimize glycaemic drift.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8016\" data-start=\"7848\"\u003e\n\u003cp data-end=\"8016\" data-start=\"7850\"\u003e\u003cstrong data-end=\"7877\" data-start=\"7850\"\u003eCombination strategies:\u003c\/strong\u003e Pair with \u003cstrong data-end=\"7911\" data-start=\"7888\"\u003eresistance exercise\u003c\/strong\u003e, \u003cstrong data-end=\"7937\" data-start=\"7913\"\u003eprotein optimization\u003c\/strong\u003e, or \u003cstrong data-end=\"7970\" data-start=\"7942\"\u003eincretin-based therapies\u003c\/strong\u003e to balance orexigeny with metabolic safety.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8098\" data-start=\"8017\"\u003e\n\u003cp data-end=\"8098\" data-start=\"8019\"\u003e\u003cstrong data-end=\"8043\" data-start=\"8019\"\u003eDDI characterization\u003c\/strong\u003e for \u003cstrong data-end=\"8058\" data-start=\"8048\"\u003eCYP3A4\u003c\/strong\u003e interactions and special-population PK.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8103\" data-start=\"8100\"\u003e\n\u003ch3 data-end=\"8128\" data-start=\"8105\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"8961\" data-start=\"8130\"\u003e\n\u003cli data-end=\"8273\" data-start=\"8130\"\u003e\n\u003cp data-end=\"8273\" data-start=\"8132\"\u003e\u003cstrong data-end=\"8211\" data-start=\"8132\"\u003eAnnals of Internal Medicine; Journal of Clinical Endocrinology \u0026amp; Metabolism\u003c\/strong\u003e — MK-677 increases IGF-1 and fat-free mass in older adults.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8374\" data-start=\"8274\"\u003e\n\u003cp data-end=\"8374\" data-start=\"8276\"\u003e\u003cstrong data-end=\"8311\" data-start=\"8276\"\u003eSleep; Psychoneuroendocrinology\u003c\/strong\u003e — Improvements in slow-wave sleep and nocturnal GH coupling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8478\" data-start=\"8375\"\u003e\n\u003cp data-end=\"8478\" data-start=\"8377\"\u003e\u003cstrong data-end=\"8413\" data-start=\"8377\"\u003eBone; Osteoporosis International\u003c\/strong\u003e — Bone-turnover markers and BMD trends under ghrelin mimetics.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8572\" data-start=\"8479\"\u003e\n\u003cp data-end=\"8572\" data-start=\"8481\"\u003e\u003cstrong data-end=\"8510\" data-start=\"8481\"\u003eDiabetes Care; Metabolism\u003c\/strong\u003e — Glycaemic effects and insulin-sensitivity considerations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8676\" data-start=\"8573\"\u003e\n\u003cp data-end=\"8676\" data-start=\"8575\"\u003e\u003cstrong data-end=\"8615\" data-start=\"8575\"\u003eClinical Pharmacology \u0026amp; Therapeutics\u003c\/strong\u003e — Oral PK\/PD characteristics of ghrelin-receptor agonists.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8793\" data-start=\"8677\"\u003e\n\u003cp data-end=\"8793\" data-start=\"8679\"\u003e\u003cstrong data-end=\"8728\" data-start=\"8679\"\u003eSupportive Care in Cancer; Clinical Nutrition\u003c\/strong\u003e — Appetite\/weight and functional recovery in catabolic states.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8873\" data-start=\"8794\"\u003e\n\u003cp data-end=\"8873\" data-start=\"8796\"\u003e\u003cstrong data-end=\"8817\" data-start=\"8796\"\u003eEndocrine Reviews\u003c\/strong\u003e — Physiology of GH pulsatility and ghrelin signaling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8961\" data-start=\"8874\"\u003e\n\u003cp data-end=\"8961\" data-start=\"8876\"\u003e\u003cstrong data-end=\"8925\" data-start=\"8876\"\u003eDrug Testing \u0026amp; Analysis; WADA Prohibited List\u003c\/strong\u003e — Anti-doping status and detection.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp style=\"text-align: center;\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684852330834,"sku":null,"price":65.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/mk677_10mg.png?v=1770834853","url":"https:\/\/sciencepeptideslab.com\/products\/mk677ibutamoren-100x10mgg","provider":"Science Peptides Lab","version":"1.0","type":"link"}